LKB1 Loss Is Associated with Resistance to Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer Mouse Models

被引：0
|
作者：
Guijarro, I. [1 ]
Poteete, A. [1 ]
Fan, Y. [1 ]
Cho, S. [1 ]
Tong, P. [1 ]
Roarty, E. [1 ]
Nilsson, M. [1 ]
Rodriguez-Canales, J. [2 ]
Mino, B. [2 ]
Cuentas, E. Parra [2 ]
Wistuba, I. [2 ]
Wang, J. [3 ]
Heymach, J. [4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] MD Anderson, Translat Mol Pathol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
LKB1; Anti-angiogenic therapy; Resistance;
D O I：
10.1016/j.jtho.2017.09.1654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03-027
引用
收藏
页码：S2283 / S2283
页数：1
相关论文
共 50 条
  • [31] LKB1 and KRAS mutations predict resistance to PI3K/Akt inhibitors in non-small cell lung cancer
    Byers, Lauren Averett
    Diao, Lixia
    Wang, Jing
    Girard, Luc
    Peyton, Michael
    Gazdar, Adi
    Groth, Philip
    Paul, Julianne
    Liu, Ningshu
    Kim, Edward S.
    Mauro, David
    Herbst, Roy S.
    Papadimitrakopoulou, Vali
    Coombes, Kevin R.
    Weinstein, John N.
    Minna, John D.
    Heymach, John V.
    CANCER RESEARCH, 2012, 72
  • [32] LKB1/AMPK/TSC2 signaling pathway alterations in non-small cell lung cancer
    De Aguirre, I
    Zhong, D
    Zhou, W
    Rosell, R
    Vertino, P
    LUNG CANCER, 2005, 49 : S69 - S69
  • [33] LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
    Shackelford, David B.
    Abt, Evan
    Gerken, Laurie
    Vasquez, Debbie S.
    Seki, Atsuko
    Leblanc, Mathias
    Wei, Liu
    Fishbein, Michael C.
    Czernin, Johannes
    Mischel, Paul S.
    Shaw, Reuben J.
    CANCER CELL, 2013, 23 (02) : 143 - 158
  • [34] Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer
    Wang, Yanning
    Gong, Xiaoling
    Hu, Yuxuan
    Yi, Qing
    Zhang, Qianning
    Miao, Liyun
    Zhou, Yujie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Dysregulation of lung developmental pathways associated with LKB1 loss in lung cancer
    Kaufman, Jacob M.
    Lowe, Cindy
    Harris, Bradford
    Boyd, Kelli
    Amann, Joseph
    Eisenberg, Rosana
    Carbone, David
    Massion, Pierre
    CANCER RESEARCH, 2016, 76
  • [36] LKB1 Mutations in Metastatic Non-Small Cell Lung Cancer (mNSCLC): Prognostic Value in the Real World
    Golozar, A.
    Collins, J.
    Fraeman, K.
    Nordstrom, B.
    Mcewen, R.
    Shire, N.
    Higgs, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S223 - S224
  • [37] Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer
    R K Gill
    S-H Yang
    D Meerzaman
    L E Mechanic
    E D Bowman
    H-S Jeon
    S Roy Chowdhuri
    A Shakoori
    T Dracheva
    K-M Hong
    J Fukuoka
    J-H Zhang
    C C Harris
    J Jen
    Oncogene, 2011, 30 : 3784 - 3791
  • [38] Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
    Tanaka, Ichidai
    Koyama, Junji
    Itoigawa, Hideyuki
    Hayai, Shunsaku
    Morise, Masahiro
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [39] Effects of phenformin in LKB1/KRAS mutated non-small cell lung cancer patient derived xenograft
    Moro, Massimo
    Roz, Luca
    Caserini, Roberto
    Pastorino, Ugo
    Sozzi, Gabriella
    CANCER RESEARCH, 2014, 74 (19)
  • [40] Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer
    Gill, R. K.
    Yang, S-H
    Meerzaman, D.
    Mechanic, L. E.
    Bowman, E. D.
    Jeon, H-S
    Chowdhuri, S. Roy
    Shakoori, A.
    Dracheva, T.
    Hong, K-M
    Fukuoka, J.
    Zhang, J-H
    Harris, C. C.
    Jen, J.
    ONCOGENE, 2011, 30 (35) : 3784 - 3791
12345